{"id":"https://openalex.org/W2021639635","doi":"https://doi.org/10.1021/jm0580555","title":"Application of a Mathematical Topological Pattern of Antihistaminic Activity for the Selection of New Drug Candidates and Pharmacology Assays","display_name":"Application of a Mathematical Topological Pattern of Antihistaminic Activity for the Selection of New Drug Candidates and Pharmacology Assays","publication_year":2006,"publication_date":"2006-05-19","ids":{"openalex":"https://openalex.org/W2021639635","doi":"https://doi.org/10.1021/jm0580555","mag":"2021639635","pmid":"https://pubmed.ncbi.nlm.nih.gov/16759109"},"language":"en","primary_location":{"id":"doi:10.1021/jm0580555","doi":"https://doi.org/10.1021/jm0580555","is_oa":false,"landing_page_url":"https://doi.org/10.1021/jm0580555","pdf_url":null,"source":{"id":"https://openalex.org/S162030435","display_name":"Journal of Medicinal Chemistry","issn_l":"0022-2623","issn":["0022-2623","1520-4804"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","jufo-3","ki-jl-2","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320006","host_organization_name":"American Chemical Society","host_organization_lineage":["https://openalex.org/P4310320006"],"host_organization_lineage_names":["American Chemical Society"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Medicinal Chemistry","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2021639635"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5076430476","display_name":"Mar\u00eda J. Duart","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I111262870","display_name":"Universitat de Miguel Hern\u00e1ndez d'Elx","ror":"https://ror.org/01azzms13","country_code":"ES","type":"education","lineage":["https://openalex.org/I111262870"]},{"id":"https://openalex.org/I16097986","display_name":"Universitat de Val\u00e8ncia","ror":"https://ror.org/043nxc105","country_code":"ES","type":"education","lineage":["https://openalex.org/I16097986"]},{"id":"https://openalex.org/I2800982320","display_name":"Universidad Cardenal Herrera CEU","ror":"https://ror.org/01tnh0829","country_code":"ES","type":"education","lineage":["https://openalex.org/I2800982320","https://openalex.org/I2801318690"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Mar\u00eda J. Duart","raw_affiliation_strings":["Departamento de Ingenier\u00eda, Divisi\u00f3n de al Farmacia y Tecnolog\u00eda Farmac\u00e9utica, Universidad Miguel Hern\u00e1ndez, Alicante, Spain, Unidad de Dise\u00f1o de F\u00e1rmacos y Conectividad Molecular, Departamento de la Qu\u00edmica F\u00edsica, Facultad de Farmacia, Universitat de Valencia, Valencia, Spain, Departamento de la Qu\u00edmica, Bioqu\u00edmica y Biolog\u00eda Molecular, Universidad Cardenal HerreraCEU, Valencia, Spain, and Departamento de la Fisiolog\u00eda, Farmacolog\u00eda y Toxicolog\u00eda, Universidad Cardenal HerreraCEU, Valencia, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Departamento de Ingenier\u00eda, Divisi\u00f3n de al Farmacia y Tecnolog\u00eda Farmac\u00e9utica, Universidad Miguel Hern\u00e1ndez, Alicante, Spain, Unidad de Dise\u00f1o de F\u00e1rmacos y Conectividad Molecular, Departamento de la Qu\u00edmica F\u00edsica, Facultad de Farmacia, Universitat de Valencia, Valencia, Spain, Departamento de la Qu\u00edmica, Bioqu\u00edmica y Biolog\u00eda Molecular, Universidad Cardenal HerreraCEU, Valencia, Spain, and Departamento de la Fisiolog\u00eda, Farmacolog\u00eda y Toxicolog\u00eda, Universidad Cardenal HerreraCEU, Valencia, Spain","institution_ids":["https://openalex.org/I111262870","https://openalex.org/I16097986","https://openalex.org/I2800982320"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5057239507","display_name":"Ram\u00f3n Garc\u00eda\u2010Domenech","orcid":"https://orcid.org/0000-0003-1137-0587","observed_orcids":["https://orcid.org/0000-0003-1137-0587"]},"institutions":[{"id":"https://openalex.org/I111262870","display_name":"Universitat de Miguel Hern\u00e1ndez d'Elx","ror":"https://ror.org/01azzms13","country_code":"ES","type":"education","lineage":["https://openalex.org/I111262870"]},{"id":"https://openalex.org/I16097986","display_name":"Universitat de Val\u00e8ncia","ror":"https://ror.org/043nxc105","country_code":"ES","type":"education","lineage":["https://openalex.org/I16097986"]},{"id":"https://openalex.org/I2800982320","display_name":"Universidad Cardenal Herrera CEU","ror":"https://ror.org/01tnh0829","country_code":"ES","type":"education","lineage":["https://openalex.org/I2800982320","https://openalex.org/I2801318690"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Ram\u00f3n Garc\u00eda-Domenech","raw_affiliation_strings":["Departamento de Ingenier\u00eda, Divisi\u00f3n de al Farmacia y Tecnolog\u00eda Farmac\u00e9utica, Universidad Miguel Hern\u00e1ndez, Alicante, Spain, Unidad de Dise\u00f1o de F\u00e1rmacos y Conectividad Molecular, Departamento de la Qu\u00edmica F\u00edsica, Facultad de Farmacia, Universitat de Valencia, Valencia, Spain, Departamento de la Qu\u00edmica, Bioqu\u00edmica y Biolog\u00eda Molecular, Universidad Cardenal HerreraCEU, Valencia, Spain, and Departamento de la Fisiolog\u00eda, Farmacolog\u00eda y Toxicolog\u00eda, Universidad Cardenal HerreraCEU, Valencia, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Departamento de Ingenier\u00eda, Divisi\u00f3n de al Farmacia y Tecnolog\u00eda Farmac\u00e9utica, Universidad Miguel Hern\u00e1ndez, Alicante, Spain, Unidad de Dise\u00f1o de F\u00e1rmacos y Conectividad Molecular, Departamento de la Qu\u00edmica F\u00edsica, Facultad de Farmacia, Universitat de Valencia, Valencia, Spain, Departamento de la Qu\u00edmica, Bioqu\u00edmica y Biolog\u00eda Molecular, Universidad Cardenal HerreraCEU, Valencia, Spain, and Departamento de la Fisiolog\u00eda, Farmacolog\u00eda y Toxicolog\u00eda, Universidad Cardenal HerreraCEU, Valencia, Spain","institution_ids":["https://openalex.org/I111262870","https://openalex.org/I16097986","https://openalex.org/I2800982320"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5084568389","display_name":"Jorge G\u00e1lvez","orcid":"https://orcid.org/0000-0003-0928-8437","observed_orcids":["https://orcid.org/0000-0003-0928-8437"]},"institutions":[{"id":"https://openalex.org/I111262870","display_name":"Universitat de Miguel Hern\u00e1ndez d'Elx","ror":"https://ror.org/01azzms13","country_code":"ES","type":"education","lineage":["https://openalex.org/I111262870"]},{"id":"https://openalex.org/I16097986","display_name":"Universitat de Val\u00e8ncia","ror":"https://ror.org/043nxc105","country_code":"ES","type":"education","lineage":["https://openalex.org/I16097986"]},{"id":"https://openalex.org/I2800982320","display_name":"Universidad Cardenal Herrera CEU","ror":"https://ror.org/01tnh0829","country_code":"ES","type":"education","lineage":["https://openalex.org/I2800982320","https://openalex.org/I2801318690"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Jorge G\u00e1lvez","raw_affiliation_strings":["Departamento de Ingenier\u00eda, Divisi\u00f3n de al Farmacia y Tecnolog\u00eda Farmac\u00e9utica, Universidad Miguel Hern\u00e1ndez, Alicante, Spain, Unidad de Dise\u00f1o de F\u00e1rmacos y Conectividad Molecular, Departamento de la Qu\u00edmica F\u00edsica, Facultad de Farmacia, Universitat de Valencia, Valencia, Spain, Departamento de la Qu\u00edmica, Bioqu\u00edmica y Biolog\u00eda Molecular, Universidad Cardenal HerreraCEU, Valencia, Spain, and Departamento de la Fisiolog\u00eda, Farmacolog\u00eda y Toxicolog\u00eda, Universidad Cardenal HerreraCEU, Valencia, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Departamento de Ingenier\u00eda, Divisi\u00f3n de al Farmacia y Tecnolog\u00eda Farmac\u00e9utica, Universidad Miguel Hern\u00e1ndez, Alicante, Spain, Unidad de Dise\u00f1o de F\u00e1rmacos y Conectividad Molecular, Departamento de la Qu\u00edmica F\u00edsica, Facultad de Farmacia, Universitat de Valencia, Valencia, Spain, Departamento de la Qu\u00edmica, Bioqu\u00edmica y Biolog\u00eda Molecular, Universidad Cardenal HerreraCEU, Valencia, Spain, and Departamento de la Fisiolog\u00eda, Farmacolog\u00eda y Toxicolog\u00eda, Universidad Cardenal HerreraCEU, Valencia, Spain","institution_ids":["https://openalex.org/I111262870","https://openalex.org/I16097986","https://openalex.org/I2800982320"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5009666583","display_name":"P. Aleman","orcid":"https://orcid.org/0000-0002-1558-0250","observed_orcids":["https://orcid.org/0000-0002-1558-0250"]},"institutions":[{"id":"https://openalex.org/I111262870","display_name":"Universitat de Miguel Hern\u00e1ndez d'Elx","ror":"https://ror.org/01azzms13","country_code":"ES","type":"education","lineage":["https://openalex.org/I111262870"]},{"id":"https://openalex.org/I16097986","display_name":"Universitat de Val\u00e8ncia","ror":"https://ror.org/043nxc105","country_code":"ES","type":"education","lineage":["https://openalex.org/I16097986"]},{"id":"https://openalex.org/I2800982320","display_name":"Universidad Cardenal Herrera CEU","ror":"https://ror.org/01tnh0829","country_code":"ES","type":"education","lineage":["https://openalex.org/I2800982320","https://openalex.org/I2801318690"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Pedro A. Alem\u00e1n","raw_affiliation_strings":["Departamento de Ingenier\u00eda, Divisi\u00f3n de al Farmacia y Tecnolog\u00eda Farmac\u00e9utica, Universidad Miguel Hern\u00e1ndez, Alicante, Spain, Unidad de Dise\u00f1o de F\u00e1rmacos y Conectividad Molecular, Departamento de la Qu\u00edmica F\u00edsica, Facultad de Farmacia, Universitat de Valencia, Valencia, Spain, Departamento de la Qu\u00edmica, Bioqu\u00edmica y Biolog\u00eda Molecular, Universidad Cardenal HerreraCEU, Valencia, Spain, and Departamento de la Fisiolog\u00eda, Farmacolog\u00eda y Toxicolog\u00eda, Universidad Cardenal HerreraCEU, Valencia, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Departamento de Ingenier\u00eda, Divisi\u00f3n de al Farmacia y Tecnolog\u00eda Farmac\u00e9utica, Universidad Miguel Hern\u00e1ndez, Alicante, Spain, Unidad de Dise\u00f1o de F\u00e1rmacos y Conectividad Molecular, Departamento de la Qu\u00edmica F\u00edsica, Facultad de Farmacia, Universitat de Valencia, Valencia, Spain, Departamento de la Qu\u00edmica, Bioqu\u00edmica y Biolog\u00eda Molecular, Universidad Cardenal HerreraCEU, Valencia, Spain, and Departamento de la Fisiolog\u00eda, Farmacolog\u00eda y Toxicolog\u00eda, Universidad Cardenal HerreraCEU, Valencia, Spain","institution_ids":["https://openalex.org/I111262870","https://openalex.org/I16097986","https://openalex.org/I2800982320"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5015357620","display_name":"Rafael V. Mart\u00edn-Algarra","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I111262870","display_name":"Universitat de Miguel Hern\u00e1ndez d'Elx","ror":"https://ror.org/01azzms13","country_code":"ES","type":"education","lineage":["https://openalex.org/I111262870"]},{"id":"https://openalex.org/I16097986","display_name":"Universitat de Val\u00e8ncia","ror":"https://ror.org/043nxc105","country_code":"ES","type":"education","lineage":["https://openalex.org/I16097986"]},{"id":"https://openalex.org/I2800982320","display_name":"Universidad Cardenal Herrera CEU","ror":"https://ror.org/01tnh0829","country_code":"ES","type":"education","lineage":["https://openalex.org/I2800982320","https://openalex.org/I2801318690"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Rafael V. Mart\u00edn-Algarra","raw_affiliation_strings":["Departamento de Ingenier\u00eda, Divisi\u00f3n de al Farmacia y Tecnolog\u00eda Farmac\u00e9utica, Universidad Miguel Hern\u00e1ndez, Alicante, Spain, Unidad de Dise\u00f1o de F\u00e1rmacos y Conectividad Molecular, Departamento de la Qu\u00edmica F\u00edsica, Facultad de Farmacia, Universitat de Valencia, Valencia, Spain, Departamento de la Qu\u00edmica, Bioqu\u00edmica y Biolog\u00eda Molecular, Universidad Cardenal HerreraCEU, Valencia, Spain, and Departamento de la Fisiolog\u00eda, Farmacolog\u00eda y Toxicolog\u00eda, Universidad Cardenal HerreraCEU, Valencia, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Departamento de Ingenier\u00eda, Divisi\u00f3n de al Farmacia y Tecnolog\u00eda Farmac\u00e9utica, Universidad Miguel Hern\u00e1ndez, Alicante, Spain, Unidad de Dise\u00f1o de F\u00e1rmacos y Conectividad Molecular, Departamento de la Qu\u00edmica F\u00edsica, Facultad de Farmacia, Universitat de Valencia, Valencia, Spain, Departamento de la Qu\u00edmica, Bioqu\u00edmica y Biolog\u00eda Molecular, Universidad Cardenal HerreraCEU, Valencia, Spain, and Departamento de la Fisiolog\u00eda, Farmacolog\u00eda y Toxicolog\u00eda, Universidad Cardenal HerreraCEU, Valencia, Spain","institution_ids":["https://openalex.org/I111262870","https://openalex.org/I16097986","https://openalex.org/I2800982320"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5008568513","display_name":"Gerardo M. Ant\u00f3n-Fos","orcid":"https://orcid.org/0000-0001-7386-5396","observed_orcids":["https://orcid.org/0000-0001-7386-5396"]},"institutions":[{"id":"https://openalex.org/I111262870","display_name":"Universitat de Miguel Hern\u00e1ndez d'Elx","ror":"https://ror.org/01azzms13","country_code":"ES","type":"education","lineage":["https://openalex.org/I111262870"]},{"id":"https://openalex.org/I16097986","display_name":"Universitat de Val\u00e8ncia","ror":"https://ror.org/043nxc105","country_code":"ES","type":"education","lineage":["https://openalex.org/I16097986"]},{"id":"https://openalex.org/I2800982320","display_name":"Universidad Cardenal Herrera CEU","ror":"https://ror.org/01tnh0829","country_code":"ES","type":"education","lineage":["https://openalex.org/I2800982320","https://openalex.org/I2801318690"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Gerardo M. Ant\u00f3n-Fos","raw_affiliation_strings":["Departamento de Ingenier\u00eda, Divisi\u00f3n de al Farmacia y Tecnolog\u00eda Farmac\u00e9utica, Universidad Miguel Hern\u00e1ndez, Alicante, Spain, Unidad de Dise\u00f1o de F\u00e1rmacos y Conectividad Molecular, Departamento de la Qu\u00edmica F\u00edsica, Facultad de Farmacia, Universitat de Valencia, Valencia, Spain, Departamento de la Qu\u00edmica, Bioqu\u00edmica y Biolog\u00eda Molecular, Universidad Cardenal HerreraCEU, Valencia, Spain, and Departamento de la Fisiolog\u00eda, Farmacolog\u00eda y Toxicolog\u00eda, Universidad Cardenal HerreraCEU, Valencia, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Departamento de Ingenier\u00eda, Divisi\u00f3n de al Farmacia y Tecnolog\u00eda Farmac\u00e9utica, Universidad Miguel Hern\u00e1ndez, Alicante, Spain, Unidad de Dise\u00f1o de F\u00e1rmacos y Conectividad Molecular, Departamento de la Qu\u00edmica F\u00edsica, Facultad de Farmacia, Universitat de Valencia, Valencia, Spain, Departamento de la Qu\u00edmica, Bioqu\u00edmica y Biolog\u00eda Molecular, Universidad Cardenal HerreraCEU, Valencia, Spain, and Departamento de la Fisiolog\u00eda, Farmacolog\u00eda y Toxicolog\u00eda, Universidad Cardenal HerreraCEU, Valencia, Spain","institution_ids":["https://openalex.org/I111262870","https://openalex.org/I16097986","https://openalex.org/I2800982320"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":4500,"currency":"USD","value_usd":4500},"apc_paid":null,"fwci":1.0099,"has_fulltext":false,"cited_by_count":26,"citation_normalized_percentile":{"value":0.66141732,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":97},"biblio":{"volume":"49","issue":"12","first_page":"3667","last_page":"3673"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10211","display_name":"Computational Drug Discovery Methods","score":0.9824000000953674,"subfield":{"id":"https://openalex.org/subfields/3002","display_name":"Drug Discovery"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10211","display_name":"Computational Drug Discovery Methods","score":0.9824000000953674,"subfield":{"id":"https://openalex.org/subfields/3002","display_name":"Drug Discovery"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11346","display_name":"Mast cells and histamine","score":0.009499999694526196,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T14099","display_name":"Synthesis and Characterization of Heterocyclic Compounds","score":0.0007999999797903001,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/antihistaminic-activity","display_name":"antihistaminic activity","score":0.972000002861023},{"id":"https://openalex.org/keywords/molecular-topology","display_name":"molecular topology","score":0.9729999899864197},{"id":"https://openalex.org/keywords/qsar","display_name":"QSAR","score":0.6660000085830688},{"id":"https://openalex.org/keywords/drug-candidate-selection","display_name":"drug candidate selection","score":0.828000009059906},{"id":"https://openalex.org/keywords/sedative-effects","display_name":"sedative effects","score":0.890999972820282},{"id":"https://openalex.org/keywords/terfenadine","display_name":"terfenadine","score":0.859000027179718},{"id":"https://openalex.org/keywords/anthracene-derivatives","display_name":"anthracene derivatives","score":0.7120000123977661},{"id":"https://openalex.org/keywords/phenol-derivatives","display_name":"phenol derivatives","score":0.7179999947547913}],"concepts":[{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.8344463109970093},{"id":"https://openalex.org/C2779303165","wikidata":"https://www.wikidata.org/wiki/Q417909","display_name":"Terfenadine","level":2,"score":0.522261917591095},{"id":"https://openalex.org/C116073593","wikidata":"https://www.wikidata.org/wiki/Q864491","display_name":"Biological activity","level":3,"score":0.48114144802093506},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.4607381224632263},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.4422568082809448},{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.4324137568473816},{"id":"https://openalex.org/C71240020","wikidata":"https://www.wikidata.org/wiki/Q186011","display_name":"Stereochemistry","level":1,"score":0.424361914396286},{"id":"https://openalex.org/C114373084","wikidata":"https://www.wikidata.org/wiki/Q273499","display_name":"Chemical synthesis","level":3,"score":0.4225846827030182},{"id":"https://openalex.org/C21951064","wikidata":"https://www.wikidata.org/wiki/Q899212","display_name":"Combinatorial chemistry","level":1,"score":0.38135388493537903},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.1655467450618744},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.14722031354904175},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.0},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.0},{"id":"https://openalex.org/C150903083","wikidata":"https://www.wikidata.org/wiki/Q7108","display_name":"Biotechnology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000814","descriptor_name":"Aniline Compounds","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D000814","descriptor_name":"Aniline Compounds","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000873","descriptor_name":"Anthracenes","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D000873","descriptor_name":"Anthracenes","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true},{"descriptor_ui":"D003872","descriptor_name":"Dermatitis","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D003872","descriptor_name":"Dermatitis","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006632","descriptor_name":"Histamine","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006634","descriptor_name":"Histamine H1 Antagonists","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D006634","descriptor_name":"Histamine H1 Antagonists","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D006634","descriptor_name":"Histamine H1 Antagonists","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true},{"descriptor_ui":"D006993","descriptor_name":"Hypnotics and Sedatives","qualifier_ui":"Q000138","qualifier_name":"chemical synthesis","is_major_topic":false},{"descriptor_ui":"D006993","descriptor_name":"Hypnotics and Sedatives","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D008433","descriptor_name":"Mathematics","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010636","descriptor_name":"Phenols","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D010636","descriptor_name":"Phenols","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D013329","descriptor_name":"Structure-Activity Relationship","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015195","descriptor_name":"Drug Design","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D016014","descriptor_name":"Linear Models","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016208","descriptor_name":"Databases, Factual","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016593","descriptor_name":"Terfenadine","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D016593","descriptor_name":"Terfenadine","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D017208","descriptor_name":"Rats, Wistar","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051381","descriptor_name":"Rats","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D052160","descriptor_name":"Benzothiazoles","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D052160","descriptor_name":"Benzothiazoles","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1021/jm0580555","doi":"https://doi.org/10.1021/jm0580555","is_oa":false,"landing_page_url":"https://doi.org/10.1021/jm0580555","pdf_url":null,"source":{"id":"https://openalex.org/S162030435","display_name":"Journal of Medicinal Chemistry","issn_l":"0022-2623","issn":["0022-2623","1520-4804"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","jufo-3","ki-jl-2","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320006","host_organization_name":"American Chemical Society","host_organization_lineage":["https://openalex.org/P4310320006"],"host_organization_lineage_names":["American Chemical Society"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Medicinal Chemistry","raw_type":"journal-article"},{"id":"pmid:16759109","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/16759109","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of medicinal chemistry","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.5683000087738037}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":10,"referenced_works":["https://openalex.org/W1480544864","https://openalex.org/W1517399704","https://openalex.org/W1605923270","https://openalex.org/W1995875735","https://openalex.org/W2030110819","https://openalex.org/W2050297026","https://openalex.org/W2059390591","https://openalex.org/W2071414619","https://openalex.org/W2129867925","https://openalex.org/W2477409058"],"related_works":["https://openalex.org/W1517399704","https://openalex.org/W2953448121","https://openalex.org/W2002587691","https://openalex.org/W2168550266","https://openalex.org/W2138329238","https://openalex.org/W4320803851","https://openalex.org/W1992588627","https://openalex.org/W2142351558","https://openalex.org/W2056973727","https://openalex.org/W2011515986"],"abstract_inverted_index":{"Molecular":[0],"topology":[1],"was":[2],"used":[3],"to":[4,14,29],"achieve":[5],"a":[6],"mathematical":[7],"model":[8,26],"capable":[9],"of":[10,24,27],"classifying":[11],"compounds":[12,43,78],"according":[13],"their":[15],"antihistaminic":[16,46,71,89],"activity":[17,28,56,90],"and":[18,34,64,85,105],"low":[19],"sedative":[20,52],"effects.":[21],"By":[22],"application":[23],"this":[25],"databases":[30],"containing":[31],"chemical":[32,62],"reagents":[33,63],"drugs":[35,66],"exhibiting":[36],"other":[37],"pharmacological":[38],"activity,":[39],"we":[40],"selected":[41],"30":[42],"with":[44,50,60],"possible":[45,51],"activity.":[47,72],"After":[48],"those":[49],"effects":[53],"were":[54,58,109],"discarded,":[55],"tests":[57],"performed":[59],"five":[61],"three":[65],"searching":[67],"for":[68,98],"in":[69],"vivo":[70],"The":[73],"obtained":[74],"results":[75],"indicate":[76],"that":[77],"such":[79],"as":[80],"4-[(E)-2-(1,3-benzothiazol-2-yl)vinyl]-N,N-dimethylaniline":[81],"(AH2),":[82],"2-ethyl-9,10-dimethoxyanthracene":[83],"(AH4),":[84],"2,4-bis(alpha,alpha-dimethylbenzyl)phenol":[86],"(AH5)":[87],"showed":[88],"above":[91],"terfenadine,":[92],"the":[93],"reference":[94],"drug,":[95],"whereas":[96],"others,":[97],"instance,":[99],"pergolide,":[100],"miconazole,":[101],"trihexyphenidyl,":[102],"2-(dibenzylamino-3-phenyl-1-propanol":[103],"(AH1),":[104],"N-benzylquininium":[106],"chloride":[107],"(AH3),":[108],"less":[110],"active":[111],"than":[112],"terfenadine.":[113]},"counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":1},{"year":2022,"cited_by_count":2},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":1},{"year":2017,"cited_by_count":3},{"year":2016,"cited_by_count":1},{"year":2013,"cited_by_count":3},{"year":2012,"cited_by_count":3}],"updated_date":"2026-11-07T11:25:07.637180","created_date":"2016-06-24T00:00:00"}
